Gland Pharma Ltd 2026 Annual Report with Sustainability Disclosures
Company: Gland Pharma Ltd
Sector: Manufacturing
Country: India
Year: 2026
Type: Annual Report with Sustainability Disclosures
Pages: 352
The report presents Gland Pharma's FY2025-26 consolidated revenue of 64,306.50 Indian Rupees millions, alongside continued expansion in complex injectables and CDMO capabilities. It sets an internal target to reduce absolute Scope 1 and Scope 2 emissions by 54.6% by FY2033-34 from a FY2023-24 baseline. The report also details energy, water, waste, workforce, safety, and CSR initiatives, with BRSR Core KPIs independently assured by DNV at a reasonable level.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.